diabetes-medication-adherence In a study, 45% of hemodialysis patients internationally reported skipping phosphate binder pills at least once in the prior month. Many hemodialysis patients face a high ...

Taking phosphate binders may lower the risk of osteoporotic fractures in patients initiating dialysis. Oral phosphate binders may decrease the risk for osteoporotic fracture in patients starting ...

Nicotinamide and Lanthanum Carbonate and Changes in Serum Phosphate and Fibroblast Growth Factor-23 in Patients With CKD: The COMBINE Trial Inclusion criteria for this randomized, double-blind, ...

Unlike phosphate binders, tenapanor decreases paracellular phosphate absorption in the intestine. Tenapanor may reduce the number of phosphate binder pills patients on hemodialysis (HD) take daily to ...

Antibody Titer Prognostic in Membranous Nephropathy Although phosphate binders lower serum and urinary phosphorus and reduce progression of secondary hyperthyroidism, they also promote progression of ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The type of ...

An observational study suggests that administration of phosphorus binders dramatically improves survival rates in patients on incident hemodialysis—even in those without hyperphosphatemia. Randomized ...

Title: Tenapanor Improves Bowel Movements in Patients with End-Stage Kidney Disease and Mild to Severe Constipation Authors: Steven Fishbane, Suling Zhao, Yang Yang, Susan Edelstein, David M. Spiegel ...

Sevelamer carbonate 800 mg; tabs. Patients with CKD can develop hyperphosphatemia as a result of retained phosphorus, which may lead to ectopic calcification. Hyperphosphatemia plays a role in the ...

NEW YORK, Nov 30 (Reuters) - An experimental drug being developed by Keryx Biopharmaceuticals Inc to lower abnormally high levels of phosphate in the blood of patients with advanced kidney disease met ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Vifor Pharma's Phase III study on its ...